Cite
MLA Citation
Malin Berling et al.. “Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.” Journal of medical economics, vol. 25, 2022, pp. 703–711. http://access.bl.uk/ark:/81055/vdc_100156456062.0x00002e